Bluesky Facebook Reddit Email

NEJM Group launches NEJM Clinician

NEJM Clinician curates highly relevant clinical insights from over 150 peer-reviewed journals to give physicians clear guidance without the noise. The weekly publication delivers summaries and commentary in a concise, 30-minute read, helping healthcare providers stay informed and confident in their decisions.

New technology for mass serological analysis

A new technology using microscopic beads marked with stable isotopes enables the simultaneous detection of dozens of different antibodies in hundreds of samples. This expands the capacity of serological analysis for biomedical research, vaccine development, and epidemiological studies.

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Pfizer-BioNTech vaccine in patients undergoing cancer treatment

A recent study published in JAMA Oncology found that the Pfizer-BioNTech vaccine appears to be safe and effective in patients with cancer, achieving satisfactory serologic status. Despite a lag in antibody production compared to non-cancer control groups, most patients experienced seroconversion after the second dose.

Estimating severity of a flu epidemic

Estimating the severity of a flu epidemic can be done in real-time using serological data coupled with clinical surveillance data. This approach provides valuable insights for pandemic preparedness and response, making it useful not only for influenza pandemics but also for other emerging infectious diseases.

Nikon Monarch 5 8x42 Binoculars

Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.

26-year study reveals optimum duration of treatment for Q fever endocarditis

A 26-year study found that 18 months of combined antibiotic therapy with doxycycline and hydroxychloroquine is sufficient to make infection undetectable in most patients, but six patients experienced serological relapse after 15-24 months. The optimal treatment duration may be longer for prosthetic valve patients.